As of 2025-12-04, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (88.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 149.03 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -159.3%.
The range of the Relative Valuation is (85.92) - (92.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 20.0x | 18.2x |
| Forward P/E multiples | 18.7x - 21.6x | 20.2x |
| Fair Price | (85.92) - (92.09) | (88.31) |
| Upside | -157.7% - -161.8% | -159.3% |
| Date | P/E |
| 2025-12-02 | -31.69 |
| 2025-12-01 | -32.40 |
| 2025-11-28 | -32.94 |
| 2025-11-26 | -32.82 |
| 2025-11-25 | -32.69 |
| 2025-11-24 | -32.87 |
| 2025-11-21 | -32.49 |
| 2025-11-20 | -31.16 |
| 2025-11-19 | -31.91 |
| 2025-11-18 | -32.06 |
| 2025-11-17 | -31.65 |
| 2025-11-14 | -30.37 |
| 2025-11-13 | -29.87 |
| 2025-11-12 | -30.62 |
| 2025-11-11 | -30.35 |
| 2025-11-10 | -29.96 |
| 2025-11-07 | -30.03 |
| 2025-11-06 | -30.31 |
| 2025-11-05 | -29.50 |
| 2025-11-04 | -29.33 |
| 2025-11-03 | -29.51 |
| 2025-10-31 | -29.35 |
| 2025-10-30 | -28.95 |
| 2025-10-29 | -28.99 |
| 2025-10-28 | -29.03 |
| 2025-10-27 | -29.28 |
| 2025-10-24 | -28.16 |
| 2025-10-23 | -27.62 |
| 2025-10-22 | -28.20 |
| 2025-10-21 | -28.56 |
| 2025-10-20 | -28.61 |
| 2025-10-17 | -27.81 |
| 2025-10-16 | -27.18 |
| 2025-10-15 | -28.17 |
| 2025-10-14 | -26.85 |
| 2025-10-13 | -26.34 |
| 2025-10-10 | -26.46 |
| 2025-10-09 | -26.64 |
| 2025-10-08 | -25.81 |
| 2025-10-07 | -25.79 |
| 2025-10-06 | -26.08 |
| 2025-10-03 | -26.15 |
| 2025-10-02 | -26.08 |
| 2025-10-01 | -25.78 |
| 2025-09-30 | -26.40 |
| 2025-09-29 | -25.57 |
| 2025-09-26 | -25.38 |
| 2025-09-25 | -25.22 |
| 2025-09-24 | -25.82 |
| 2025-09-23 | -25.69 |